Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alseres Pharmaceuticals, Inc.
Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
April 18th, 2008
Alseres Pharmaceuticals, Inc. (NASDAQ:ALSE) reported consolidated financial results for the year ended December 31, 2007 and company highlights. "2007 was a year of significant clinical, regulatory, pipeline and business accomplishments that helped advance our mission of building a leading biopharmaceutical company focused on disorders of the central nervous system," commented Peter G. Savas, Chairman and Chief Executive Officer of Alseres. "Our progress reinforces our confidence in the broad potential of our pipeline and in our leadership in nerve repair and regenerative therapeutics. Our focus in 2008 will be on commencing the Phase IIb trial of CETHRIN, partnering...
Source: Health Business Week (2008-04-18)
|
